nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—obesity	0.286	1	CbGaD
Loperamide—Toremifene—Benzphetamine—obesity	0.0475	0.16	CrCrCtD
Loperamide—Isopropamide—Benzphetamine—obesity	0.0378	0.127	CrCrCtD
Loperamide—Tamoxifen—Benzphetamine—obesity	0.0326	0.11	CrCrCtD
Loperamide—CYP2B6—Benzphetamine—obesity	0.0322	0.157	CbGbCtD
Loperamide—Levomethadyl Acetate—Benzphetamine—obesity	0.0316	0.107	CrCrCtD
Loperamide—Methadyl Acetate—Benzphetamine—obesity	0.0316	0.107	CrCrCtD
Loperamide—CYP2B6—Bupropion—obesity	0.0274	0.133	CbGbCtD
Loperamide—Diphenidol—Benzphetamine—obesity	0.0259	0.0874	CrCrCtD
Loperamide—Dextropropoxyphene—Benzphetamine—obesity	0.0259	0.0874	CrCrCtD
Loperamide—Fentanyl—Benzphetamine—obesity	0.0231	0.0778	CrCrCtD
Loperamide—Methadone—Benzphetamine—obesity	0.0217	0.0731	CrCrCtD
Loperamide—CYP2C8—Bupropion—obesity	0.0207	0.101	CbGbCtD
Loperamide—Clofedanol—Benzphetamine—obesity	0.0187	0.0632	CrCrCtD
Loperamide—CYP2D6—Phentermine—obesity	0.0156	0.0758	CbGbCtD
Loperamide—CYP2C8—Cimetidine—obesity	0.0152	0.0742	CbGbCtD
Loperamide—CYP2D6—Bupropion—obesity	0.0132	0.0645	CbGbCtD
Loperamide—CYP3A4—Sibutramine—obesity	0.0131	0.0636	CbGbCtD
Loperamide—CYP2D6—Methamphetamine—obesity	0.0124	0.0606	CbGbCtD
Loperamide—ABCB1—Cimetidine—obesity	0.0103	0.0502	CbGbCtD
Loperamide—CYP3A4—Benzphetamine—obesity	0.0099	0.0482	CbGbCtD
Loperamide—CYP2D6—Cimetidine—obesity	0.00971	0.0473	CbGbCtD
Loperamide—CYP3A4—Bupropion—obesity	0.00842	0.041	CbGbCtD
Loperamide—CYP3A4—Orlistat—obesity	0.00686	0.0334	CbGbCtD
Loperamide—POMC—sympathetic nervous system—obesity	0.00671	0.132	CbGeAlD
Loperamide—POMC—vagus nerve—obesity	0.0065	0.128	CbGeAlD
Loperamide—CYP3A4—Cimetidine—obesity	0.00618	0.0301	CbGbCtD
Loperamide—POMC—brown adipose tissue—obesity	0.00581	0.114	CbGeAlD
Loperamide—POMC—autonomic nervous system—obesity	0.00451	0.0888	CbGeAlD
Loperamide—Abdominal colic—Orlistat—obesity	0.0041	0.0666	CcSEcCtD
Loperamide—CYP3A4—Topiramate—obesity	0.00404	0.0197	CbGbCtD
Loperamide—POMC—hindbrain—obesity	0.0019	0.0374	CbGeAlD
Loperamide—CALM1—sympathetic nervous system—obesity	0.00182	0.0359	CbGeAlD
Loperamide—CACNA1A—hindbrain—obesity	0.00181	0.0357	CbGeAlD
Loperamide—Abdominal cramps—Phentermine—obesity	0.0018	0.0292	CcSEcCtD
Loperamide—Bullous eruption—Orlistat—obesity	0.0014	0.0228	CcSEcCtD
Loperamide—CALM1—autonomic nervous system—obesity	0.00123	0.0241	CbGeAlD
Loperamide—CACNA1A—islet of Langerhans—obesity	0.00117	0.0231	CbGeAlD
Loperamide—POMC—respiratory system—obesity	0.00116	0.0228	CbGeAlD
Loperamide—Altered state of consciousness—Bupropion—obesity	0.00101	0.0165	CcSEcCtD
Loperamide—Abdominal pain upper—Phendimetrazine—obesity	0.000984	0.016	CcSEcCtD
Loperamide—POMC—adrenal cortex—obesity	0.000974	0.0192	CbGeAlD
Loperamide—POMC—cardiovascular system—obesity	0.000889	0.0175	CbGeAlD
Loperamide—Urinary retention—Phenylpropanolamine—obesity	0.000875	0.0142	CcSEcCtD
Loperamide—POMC—pituitary gland—obesity	0.000787	0.0155	CbGeAlD
Loperamide—POMC—adipose tissue—obesity	0.000784	0.0154	CbGeAlD
Loperamide—POMC—digestive system—obesity	0.000738	0.0145	CbGeAlD
Loperamide—Drowsiness—Phenylpropanolamine—obesity	0.000709	0.0115	CcSEcCtD
Loperamide—POMC—adrenal gland—obesity	0.000703	0.0138	CbGeAlD
Loperamide—Urinary retention—Cimetidine—obesity	0.000693	0.0113	CcSEcCtD
Loperamide—CACNA1A—adrenal gland—obesity	0.000671	0.0132	CbGeAlD
Loperamide—Toxic epidermal necrolysis—Cimetidine—obesity	0.000656	0.0107	CcSEcCtD
Loperamide—Altered state of consciousness—Topiramate—obesity	0.000646	0.0105	CcSEcCtD
Loperamide—POMC—endocrine gland—obesity	0.00061	0.012	CbGeAlD
Loperamide—Drowsiness—Diethylpropion—obesity	0.00059	0.0096	CcSEcCtD
Loperamide—Drowsiness—Cimetidine—obesity	0.000562	0.00913	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Cimetidine—obesity	0.000557	0.00905	CcSEcCtD
Loperamide—POMC—liver—obesity	0.00055	0.0108	CbGeAlD
Loperamide—Dyspepsia—Methamphetamine—obesity	0.00053	0.00862	CcSEcCtD
Loperamide—Gastrointestinal disorder—Methamphetamine—obesity	0.00052	0.00846	CcSEcCtD
Loperamide—CALM2—hindbrain—obesity	0.000519	0.0102	CbGeAlD
Loperamide—CALM1—hindbrain—obesity	0.000517	0.0102	CbGeAlD
Loperamide—Constipation—Methamphetamine—obesity	0.000515	0.00838	CcSEcCtD
Loperamide—CALM2—gall bladder—obesity	0.000512	0.0101	CbGeAlD
Loperamide—Dyspepsia—Benzphetamine—obesity	0.000511	0.00831	CcSEcCtD
Loperamide—Gastrointestinal disorder—Benzphetamine—obesity	0.000502	0.00815	CcSEcCtD
Loperamide—Urticaria—Methamphetamine—obesity	0.000479	0.00778	CcSEcCtD
Loperamide—Erythema multiforme—Cimetidine—obesity	0.000477	0.00775	CcSEcCtD
Loperamide—Urticaria—Benzphetamine—obesity	0.000462	0.0075	CcSEcCtD
Loperamide—Constipation—Phendimetrazine—obesity	0.000453	0.00736	CcSEcCtD
Loperamide—Depressed level of consciousness—Bupropion—obesity	0.000452	0.00734	CcSEcCtD
Loperamide—Hypersensitivity—Methamphetamine—obesity	0.000444	0.00722	CcSEcCtD
Loperamide—Dry mouth—Phentermine—obesity	0.000442	0.00718	CcSEcCtD
Loperamide—Flatulence—Cimetidine—obesity	0.000433	0.00703	CcSEcCtD
Loperamide—Hypersensitivity—Benzphetamine—obesity	0.000428	0.00696	CcSEcCtD
Loperamide—CALM3—islet of Langerhans—obesity	0.000428	0.00841	CbGeAlD
Loperamide—Dermatitis bullous—Orlistat—obesity	0.000421	0.00685	CcSEcCtD
Loperamide—Abdominal pain—Phendimetrazine—obesity	0.000419	0.0068	CcSEcCtD
Loperamide—Diarrhoea—Methamphetamine—obesity	0.000412	0.0067	CcSEcCtD
Loperamide—Dermatitis bullous—Sibutramine—obesity	0.000408	0.00662	CcSEcCtD
Loperamide—Anaphylactoid reaction—Sibutramine—obesity	0.000402	0.00654	CcSEcCtD
Loperamide—Somnolence—Phenylpropanolamine—obesity	0.000402	0.00654	CcSEcCtD
Loperamide—Dizziness—Methamphetamine—obesity	0.000398	0.00648	CcSEcCtD
Loperamide—Diarrhoea—Benzphetamine—obesity	0.000398	0.00646	CcSEcCtD
Loperamide—Discomfort—Diethylpropion—obesity	0.000388	0.00631	CcSEcCtD
Loperamide—Constipation—Phenylpropanolamine—obesity	0.000387	0.00629	CcSEcCtD
Loperamide—Dizziness—Benzphetamine—obesity	0.000384	0.00625	CcSEcCtD
Loperamide—Dry mouth—Diethylpropion—obesity	0.000384	0.00624	CcSEcCtD
Loperamide—Dyspepsia—Phentermine—obesity	0.000381	0.00619	CcSEcCtD
Loperamide—Headache—Methamphetamine—obesity	0.000377	0.00614	CcSEcCtD
Loperamide—Gastrointestinal disorder—Phentermine—obesity	0.000374	0.00607	CcSEcCtD
Loperamide—Fatigue—Phentermine—obesity	0.000373	0.00607	CcSEcCtD
Loperamide—Urinary retention—Sibutramine—obesity	0.00037	0.00602	CcSEcCtD
Loperamide—Constipation—Phentermine—obesity	0.00037	0.00602	CcSEcCtD
Loperamide—Abdominal pain upper—Orlistat—obesity	0.000368	0.00598	CcSEcCtD
Loperamide—Headache—Benzphetamine—obesity	0.000364	0.00592	CcSEcCtD
Loperamide—Diarrhoea—Phendimetrazine—obesity	0.000362	0.00589	CcSEcCtD
Loperamide—Anaphylactic shock—Cimetidine—obesity	0.000358	0.00582	CcSEcCtD
Loperamide—Abdominal distension—Orlistat—obesity	0.00035	0.00569	CcSEcCtD
Loperamide—Dizziness—Phendimetrazine—obesity	0.00035	0.00569	CcSEcCtD
Loperamide—Nausea—Benzphetamine—obesity	0.000345	0.00561	CcSEcCtD
Loperamide—Urticaria—Phentermine—obesity	0.000344	0.00559	CcSEcCtD
Loperamide—Abdominal pain—Phentermine—obesity	0.000342	0.00556	CcSEcCtD
Loperamide—Abdominal distension—Sibutramine—obesity	0.000339	0.00551	CcSEcCtD
Loperamide—CALM3—adrenal cortex—obesity	0.000339	0.00667	CbGeAlD
Loperamide—CALM2—islet of Langerhans—obesity	0.000336	0.00661	CbGeAlD
Loperamide—Somnolence—Diethylpropion—obesity	0.000335	0.00544	CcSEcCtD
Loperamide—CALM1—islet of Langerhans—obesity	0.000334	0.00658	CbGeAlD
Loperamide—Hypersensitivity—Phenylpropanolamine—obesity	0.000333	0.00542	CcSEcCtD
Loperamide—Headache—Phendimetrazine—obesity	0.000332	0.00539	CcSEcCtD
Loperamide—Dyspepsia—Diethylpropion—obesity	0.000331	0.00539	CcSEcCtD
Loperamide—Gastrointestinal disorder—Diethylpropion—obesity	0.000325	0.00528	CcSEcCtD
Loperamide—Urinary retention—Bupropion—obesity	0.000323	0.00525	CcSEcCtD
Loperamide—Constipation—Diethylpropion—obesity	0.000322	0.00523	CcSEcCtD
Loperamide—Somnolence—Cimetidine—obesity	0.000319	0.00518	CcSEcCtD
Loperamide—CALM2—respiratory system—obesity	0.000317	0.00624	CbGeAlD
Loperamide—CALM1—respiratory system—obesity	0.000316	0.00621	CbGeAlD
Loperamide—Nausea—Phendimetrazine—obesity	0.000315	0.00511	CcSEcCtD
Loperamide—Asthenia—Phentermine—obesity	0.000311	0.00505	CcSEcCtD
Loperamide—Abdominal pain upper—Bupropion—obesity	0.00031	0.00504	CcSEcCtD
Loperamide—Fatigue—Cimetidine—obesity	0.000309	0.00502	CcSEcCtD
Loperamide—Constipation—Cimetidine—obesity	0.000306	0.00498	CcSEcCtD
Loperamide—Urticaria—Diethylpropion—obesity	0.000299	0.00486	CcSEcCtD
Loperamide—Dizziness—Phenylpropanolamine—obesity	0.000299	0.00486	CcSEcCtD
Loperamide—Diarrhoea—Phentermine—obesity	0.000296	0.00481	CcSEcCtD
Loperamide—Abdominal distension—Bupropion—obesity	0.000295	0.0048	CcSEcCtD
Loperamide—Depressed level of consciousness—Topiramate—obesity	0.000288	0.00468	CcSEcCtD
Loperamide—Vomiting—Phenylpropanolamine—obesity	0.000288	0.00468	CcSEcCtD
Loperamide—CYP2D6—hindbrain—obesity	0.000287	0.00564	CbGeAlD
Loperamide—Dizziness—Phentermine—obesity	0.000286	0.00465	CcSEcCtD
Loperamide—Rash—Phenylpropanolamine—obesity	0.000285	0.00464	CcSEcCtD
Loperamide—Dermatitis—Phenylpropanolamine—obesity	0.000285	0.00463	CcSEcCtD
Loperamide—Vomiting—Phentermine—obesity	0.000275	0.00447	CcSEcCtD
Loperamide—Urinary tract disorder—Orlistat—obesity	0.000275	0.00447	CcSEcCtD
Loperamide—CALM3—pituitary gland—obesity	0.000274	0.00539	CbGeAlD
Loperamide—Urethral disorder—Orlistat—obesity	0.000273	0.00444	CcSEcCtD
Loperamide—Rash—Phentermine—obesity	0.000273	0.00444	CcSEcCtD
Loperamide—Dermatitis—Phentermine—obesity	0.000273	0.00443	CcSEcCtD
Loperamide—CALM3—adipose tissue—obesity	0.000273	0.00537	CbGeAlD
Loperamide—Headache—Phentermine—obesity	0.000271	0.00441	CcSEcCtD
Loperamide—Nausea—Phenylpropanolamine—obesity	0.000269	0.00437	CcSEcCtD
Loperamide—CALM2—adrenal cortex—obesity	0.000266	0.00524	CbGeAlD
Loperamide—CALM1—adrenal cortex—obesity	0.000265	0.00521	CbGeAlD
Loperamide—Hypersensitivity—Cimetidine—obesity	0.000264	0.00429	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Bupropion—obesity	0.000259	0.00422	CcSEcCtD
Loperamide—Diarrhoea—Diethylpropion—obesity	0.000258	0.00419	CcSEcCtD
Loperamide—Nausea—Phentermine—obesity	0.000257	0.00418	CcSEcCtD
Loperamide—Asthenia—Cimetidine—obesity	0.000257	0.00418	CcSEcCtD
Loperamide—Immune system disorder—Orlistat—obesity	0.000252	0.00409	CcSEcCtD
Loperamide—Dizziness—Diethylpropion—obesity	0.000249	0.00405	CcSEcCtD
Loperamide—Diarrhoea—Cimetidine—obesity	0.000245	0.00399	CcSEcCtD
Loperamide—CALM3—adrenal gland—obesity	0.000245	0.00481	CbGeAlD
Loperamide—Immune system disorder—Sibutramine—obesity	0.000243	0.00396	CcSEcCtD
Loperamide—CALM2—cardiovascular system—obesity	0.000243	0.00478	CbGeAlD
Loperamide—CALM1—cardiovascular system—obesity	0.000242	0.00476	CbGeAlD
Loperamide—Vomiting—Diethylpropion—obesity	0.000239	0.00389	CcSEcCtD
Loperamide—Flatulence—Orlistat—obesity	0.000239	0.00388	CcSEcCtD
Loperamide—Rash—Diethylpropion—obesity	0.000237	0.00386	CcSEcCtD
Loperamide—Dermatitis—Diethylpropion—obesity	0.000237	0.00386	CcSEcCtD
Loperamide—Dizziness—Cimetidine—obesity	0.000237	0.00385	CcSEcCtD
Loperamide—Headache—Diethylpropion—obesity	0.000236	0.00383	CcSEcCtD
Loperamide—CYP2B6—respiratory system—obesity	0.000236	0.00464	CbGeAlD
Loperamide—Urinary tract disorder—Bupropion—obesity	0.000232	0.00377	CcSEcCtD
Loperamide—Flatulence—Sibutramine—obesity	0.000231	0.00376	CcSEcCtD
Loperamide—Urethral disorder—Bupropion—obesity	0.00023	0.00374	CcSEcCtD
Loperamide—OPRM1—endocrine gland—obesity	0.00023	0.00452	CbGeAlD
Loperamide—Vomiting—Cimetidine—obesity	0.000228	0.0037	CcSEcCtD
Loperamide—Rash—Cimetidine—obesity	0.000226	0.00367	CcSEcCtD
Loperamide—Dermatitis—Cimetidine—obesity	0.000226	0.00367	CcSEcCtD
Loperamide—Headache—Cimetidine—obesity	0.000224	0.00365	CcSEcCtD
Loperamide—Nausea—Diethylpropion—obesity	0.000224	0.00364	CcSEcCtD
Loperamide—Erythema multiforme—Bupropion—obesity	0.000222	0.00361	CcSEcCtD
Loperamide—Tamoxifen—CES1—obesity	0.000222	0.158	CrCbGaD
Loperamide—Angioedema—Orlistat—obesity	0.000221	0.0036	CcSEcCtD
Loperamide—CALM2—pituitary gland—obesity	0.000215	0.00423	CbGeAlD
Loperamide—Angioedema—Sibutramine—obesity	0.000214	0.00348	CcSEcCtD
Loperamide—CALM2—adipose tissue—obesity	0.000214	0.00421	CbGeAlD
Loperamide—CALM1—pituitary gland—obesity	0.000214	0.00421	CbGeAlD
Loperamide—CALM1—adipose tissue—obesity	0.000213	0.00419	CbGeAlD
Loperamide—Nausea—Cimetidine—obesity	0.000213	0.00346	CcSEcCtD
Loperamide—Immune system disorder—Bupropion—obesity	0.000212	0.00345	CcSEcCtD
Loperamide—Loss of consciousness—Sibutramine—obesity	0.000206	0.00335	CcSEcCtD
Loperamide—Urinary retention—Topiramate—obesity	0.000206	0.00334	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000205	0.00333	CcSEcCtD
Loperamide—Discomfort—Orlistat—obesity	0.000204	0.00331	CcSEcCtD
Loperamide—Dry mouth—Orlistat—obesity	0.000202	0.00328	CcSEcCtD
Loperamide—CALM2—digestive system—obesity	0.000202	0.00397	CbGeAlD
Loperamide—Flatulence—Bupropion—obesity	0.000202	0.00328	CcSEcCtD
Loperamide—CALM1—digestive system—obesity	0.000201	0.00395	CbGeAlD
Loperamide—Anaphylactic shock—Orlistat—obesity	0.000198	0.00322	CcSEcCtD
Loperamide—CYP2B6—adrenal cortex—obesity	0.000198	0.00389	CbGeAlD
Loperamide—Abdominal pain upper—Topiramate—obesity	0.000198	0.00321	CcSEcCtD
Loperamide—Discomfort—Sibutramine—obesity	0.000197	0.00321	CcSEcCtD
Loperamide—Dry mouth—Sibutramine—obesity	0.000195	0.00317	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Topiramate—obesity	0.000195	0.00317	CcSEcCtD
Loperamide—Nervous system disorder—Orlistat—obesity	0.000194	0.00315	CcSEcCtD
Loperamide—Skin disorder—Orlistat—obesity	0.000192	0.00312	CcSEcCtD
Loperamide—CALM2—adrenal gland—obesity	0.000192	0.00378	CbGeAlD
Loperamide—Anaphylactic shock—Sibutramine—obesity	0.000191	0.00311	CcSEcCtD
Loperamide—CALM3—liver—obesity	0.000191	0.00376	CbGeAlD
Loperamide—CALM1—adrenal gland—obesity	0.000191	0.00376	CbGeAlD
Loperamide—Abdominal distension—Topiramate—obesity	0.000188	0.00306	CcSEcCtD
Loperamide—Angioedema—Bupropion—obesity	0.000187	0.00304	CcSEcCtD
Loperamide—Skin disorder—Sibutramine—obesity	0.000186	0.00302	CcSEcCtD
Loperamide—CYP2B6—cardiovascular system—obesity	0.000181	0.00355	CbGeAlD
Loperamide—Loss of consciousness—Bupropion—obesity	0.00018	0.00292	CcSEcCtD
Loperamide—CYP2C8—pituitary gland—obesity	0.000178	0.00351	CbGeAlD
Loperamide—Dyspepsia—Orlistat—obesity	0.000174	0.00283	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000173	0.00281	CcSEcCtD
Loperamide—Discomfort—Bupropion—obesity	0.000172	0.0028	CcSEcCtD
Loperamide—Gastrointestinal disorder—Orlistat—obesity	0.000171	0.00278	CcSEcCtD
Loperamide—Fatigue—Orlistat—obesity	0.000171	0.00277	CcSEcCtD
Loperamide—Dry mouth—Bupropion—obesity	0.00017	0.00277	CcSEcCtD
Loperamide—Somnolence—Sibutramine—obesity	0.00017	0.00277	CcSEcCtD
Loperamide—Dyspepsia—Sibutramine—obesity	0.000169	0.00274	CcSEcCtD
Loperamide—Anaphylactic shock—Bupropion—obesity	0.000167	0.00271	CcSEcCtD
Loperamide—CALM2—endocrine gland—obesity	0.000167	0.00328	CbGeAlD
Loperamide—CALM1—endocrine gland—obesity	0.000166	0.00326	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Topiramate—obesity	0.000165	0.00269	CcSEcCtD
Loperamide—Gastrointestinal disorder—Sibutramine—obesity	0.000165	0.00269	CcSEcCtD
Loperamide—Constipation—Sibutramine—obesity	0.000164	0.00266	CcSEcCtD
Loperamide—Nervous system disorder—Bupropion—obesity	0.000164	0.00266	CcSEcCtD
Loperamide—Skin disorder—Bupropion—obesity	0.000162	0.00264	CcSEcCtD
Loperamide—Gastrointestinal pain—Orlistat—obesity	0.000162	0.00263	CcSEcCtD
Loperamide—Urticaria—Orlistat—obesity	0.000157	0.00255	CcSEcCtD
Loperamide—Gastrointestinal pain—Sibutramine—obesity	0.000157	0.00254	CcSEcCtD
Loperamide—Abdominal pain—Orlistat—obesity	0.000156	0.00254	CcSEcCtD
Loperamide—Urticaria—Sibutramine—obesity	0.000152	0.00247	CcSEcCtD
Loperamide—Abdominal pain—Sibutramine—obesity	0.000151	0.00246	CcSEcCtD
Loperamide—CALM2—liver—obesity	0.00015	0.00296	CbGeAlD
Loperamide—CYP2B6—digestive system—obesity	0.00015	0.00295	CbGeAlD
Loperamide—CALM1—liver—obesity	0.000149	0.00294	CbGeAlD
Loperamide—Somnolence—Bupropion—obesity	0.000148	0.00241	CcSEcCtD
Loperamide—Urinary tract disorder—Topiramate—obesity	0.000148	0.0024	CcSEcCtD
Loperamide—Dyspepsia—Bupropion—obesity	0.000147	0.00239	CcSEcCtD
Loperamide—Urethral disorder—Topiramate—obesity	0.000147	0.00238	CcSEcCtD
Loperamide—Hypersensitivity—Orlistat—obesity	0.000146	0.00237	CcSEcCtD
Loperamide—Gastrointestinal disorder—Bupropion—obesity	0.000144	0.00234	CcSEcCtD
Loperamide—Fatigue—Bupropion—obesity	0.000144	0.00234	CcSEcCtD
Loperamide—CYP2B6—adrenal gland—obesity	0.000143	0.00281	CbGeAlD
Loperamide—Constipation—Bupropion—obesity	0.000143	0.00232	CcSEcCtD
Loperamide—Asthenia—Orlistat—obesity	0.000142	0.00231	CcSEcCtD
Loperamide—Erythema multiforme—Topiramate—obesity	0.000142	0.0023	CcSEcCtD
Loperamide—Hypersensitivity—Sibutramine—obesity	0.000141	0.00229	CcSEcCtD
Loperamide—Pruritus—Orlistat—obesity	0.00014	0.00227	CcSEcCtD
Loperamide—Toremifene—ESR1—obesity	0.000139	0.099	CrCbGaD
Loperamide—CYP2C8—endocrine gland—obesity	0.000138	0.00272	CbGeAlD
Loperamide—Asthenia—Sibutramine—obesity	0.000137	0.00223	CcSEcCtD
Loperamide—Gastrointestinal pain—Bupropion—obesity	0.000136	0.00222	CcSEcCtD
Loperamide—Pruritus—Sibutramine—obesity	0.000135	0.0022	CcSEcCtD
Loperamide—Diarrhoea—Orlistat—obesity	0.000135	0.0022	CcSEcCtD
Loperamide—Immune system disorder—Topiramate—obesity	0.000135	0.0022	CcSEcCtD
Loperamide—ABCB1—islet of Langerhans—obesity	0.000133	0.00263	CbGeAlD
Loperamide—Urticaria—Bupropion—obesity	0.000133	0.00216	CcSEcCtD
Loperamide—Abdominal pain—Bupropion—obesity	0.000132	0.00214	CcSEcCtD
Loperamide—Diarrhoea—Sibutramine—obesity	0.000131	0.00213	CcSEcCtD
Loperamide—Dizziness—Orlistat—obesity	0.000131	0.00213	CcSEcCtD
Loperamide—Flatulence—Topiramate—obesity	0.000128	0.00209	CcSEcCtD
Loperamide—Dizziness—Sibutramine—obesity	0.000127	0.00206	CcSEcCtD
Loperamide—ABCB1—respiratory system—obesity	0.000126	0.00248	CbGeAlD
Loperamide—Vomiting—Orlistat—obesity	0.000126	0.00204	CcSEcCtD
Loperamide—Rash—Orlistat—obesity	0.000125	0.00203	CcSEcCtD
Loperamide—Dermatitis—Orlistat—obesity	0.000125	0.00203	CcSEcCtD
Loperamide—CYP2C8—liver—obesity	0.000124	0.00245	CbGeAlD
Loperamide—Headache—Orlistat—obesity	0.000124	0.00201	CcSEcCtD
Loperamide—CYP2B6—endocrine gland—obesity	0.000124	0.00244	CbGeAlD
Loperamide—Hypersensitivity—Bupropion—obesity	0.000123	0.002	CcSEcCtD
Loperamide—Vomiting—Sibutramine—obesity	0.000122	0.00198	CcSEcCtD
Loperamide—Rash—Sibutramine—obesity	0.000121	0.00196	CcSEcCtD
Loperamide—Dermatitis—Sibutramine—obesity	0.000121	0.00196	CcSEcCtD
Loperamide—Headache—Sibutramine—obesity	0.00012	0.00195	CcSEcCtD
Loperamide—Asthenia—Bupropion—obesity	0.00012	0.00195	CcSEcCtD
Loperamide—Haloperidol—DRD4—obesity	0.000119	0.0849	CrCbGaD
Loperamide—Pruritus—Bupropion—obesity	0.000118	0.00192	CcSEcCtD
Loperamide—Nausea—Orlistat—obesity	0.000118	0.00191	CcSEcCtD
Loperamide—Loss of consciousness—Topiramate—obesity	0.000115	0.00186	CcSEcCtD
Loperamide—Diarrhoea—Bupropion—obesity	0.000114	0.00186	CcSEcCtD
Loperamide—Nausea—Sibutramine—obesity	0.000114	0.00185	CcSEcCtD
Loperamide—CYP3A4—digestive system—obesity	0.000113	0.00223	CbGeAlD
Loperamide—CYP2B6—liver—obesity	0.000112	0.0022	CbGeAlD
Loperamide—CYP2D6—digestive system—obesity	0.000111	0.00219	CbGeAlD
Loperamide—Dizziness—Bupropion—obesity	0.00011	0.00179	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00011	0.00179	CcSEcCtD
Loperamide—Discomfort—Topiramate—obesity	0.00011	0.00178	CcSEcCtD
Loperamide—Dry mouth—Topiramate—obesity	0.000108	0.00176	CcSEcCtD
Loperamide—Vomiting—Bupropion—obesity	0.000106	0.00172	CcSEcCtD
Loperamide—Haloperidol—HTR1B—obesity	0.000106	0.0754	CrCbGaD
Loperamide—ABCB1—adrenal cortex—obesity	0.000106	0.00208	CbGeAlD
Loperamide—Rash—Bupropion—obesity	0.000105	0.00171	CcSEcCtD
Loperamide—Dermatitis—Bupropion—obesity	0.000105	0.00171	CcSEcCtD
Loperamide—Headache—Bupropion—obesity	0.000105	0.0017	CcSEcCtD
Loperamide—Nervous system disorder—Topiramate—obesity	0.000104	0.0017	CcSEcCtD
Loperamide—Skin disorder—Topiramate—obesity	0.000103	0.00168	CcSEcCtD
Loperamide—Levomethadyl Acetate—CYP19A1—obesity	0.000102	0.0727	CrCbGaD
Loperamide—Clotrimazole—CYP19A1—obesity	0.000102	0.0727	CrCbGaD
Loperamide—Haloperidol—DRD1—obesity	0.000101	0.0719	CrCbGaD
Loperamide—Nausea—Bupropion—obesity	9.91e-05	0.00161	CcSEcCtD
Loperamide—ABCB1—cardiovascular system—obesity	9.65e-05	0.0019	CbGeAlD
Loperamide—Somnolence—Topiramate—obesity	9.45e-05	0.00154	CcSEcCtD
Loperamide—Dyspepsia—Topiramate—obesity	9.36e-05	0.00152	CcSEcCtD
Loperamide—CYP3A4—endocrine gland—obesity	9.35e-05	0.00184	CbGeAlD
Loperamide—CYP2D6—endocrine gland—obesity	9.2e-05	0.00181	CbGeAlD
Loperamide—Gastrointestinal disorder—Topiramate—obesity	9.18e-05	0.00149	CcSEcCtD
Loperamide—Fatigue—Topiramate—obesity	9.17e-05	0.00149	CcSEcCtD
Loperamide—Constipation—Topiramate—obesity	9.09e-05	0.00148	CcSEcCtD
Loperamide—Tamoxifen—ESR2—obesity	9.01e-05	0.0642	CrCbGaD
Loperamide—Gastrointestinal pain—Topiramate—obesity	8.7e-05	0.00141	CcSEcCtD
Loperamide—ABCB1—pituitary gland—obesity	8.54e-05	0.00168	CbGeAlD
Loperamide—ABCB1—adipose tissue—obesity	8.51e-05	0.00167	CbGeAlD
Loperamide—Urticaria—Topiramate—obesity	8.45e-05	0.00137	CcSEcCtD
Loperamide—CYP3A4—liver—obesity	8.43e-05	0.00166	CbGeAlD
Loperamide—Abdominal pain—Topiramate—obesity	8.41e-05	0.00137	CcSEcCtD
Loperamide—CYP2D6—liver—obesity	8.3e-05	0.00163	CbGeAlD
Loperamide—ABCB1—digestive system—obesity	8.01e-05	0.00158	CbGeAlD
Loperamide—Hypersensitivity—Topiramate—obesity	7.83e-05	0.00127	CcSEcCtD
Loperamide—ABCB1—adrenal gland—obesity	7.63e-05	0.0015	CbGeAlD
Loperamide—Asthenia—Topiramate—obesity	7.63e-05	0.00124	CcSEcCtD
Loperamide—Clotrimazole—CYP2E1—obesity	7.61e-05	0.0542	CrCbGaD
Loperamide—Pruritus—Topiramate—obesity	7.52e-05	0.00122	CcSEcCtD
Loperamide—Diarrhoea—Topiramate—obesity	7.28e-05	0.00118	CcSEcCtD
Loperamide—Haloperidol—DRD2—obesity	7.12e-05	0.0507	CrCbGaD
Loperamide—Dizziness—Topiramate—obesity	7.03e-05	0.00114	CcSEcCtD
Loperamide—Vomiting—Topiramate—obesity	6.76e-05	0.0011	CcSEcCtD
Loperamide—Rash—Topiramate—obesity	6.7e-05	0.00109	CcSEcCtD
Loperamide—Dermatitis—Topiramate—obesity	6.7e-05	0.00109	CcSEcCtD
Loperamide—Headache—Topiramate—obesity	6.66e-05	0.00108	CcSEcCtD
Loperamide—ABCB1—endocrine gland—obesity	6.62e-05	0.0013	CbGeAlD
Loperamide—Nausea—Topiramate—obesity	6.32e-05	0.00103	CcSEcCtD
Loperamide—Tamoxifen—CYP19A1—obesity	6.03e-05	0.043	CrCbGaD
Loperamide—Methadone—CYP19A1—obesity	5.98e-05	0.0426	CrCbGaD
Loperamide—ABCB1—liver—obesity	5.97e-05	0.00117	CbGeAlD
Loperamide—Tamoxifen—ESR1—obesity	5.55e-05	0.0395	CrCbGaD
Loperamide—Haloperidol—HTR2A—obesity	5.5e-05	0.0392	CrCbGaD
Loperamide—Tamoxifen—CYP2E1—obesity	4.5e-05	0.032	CrCbGaD
Loperamide—CYP3A4—Metabolism—FASN—obesity	9.15e-07	9.31e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—BAD—obesity	9.15e-07	9.31e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—BCHE—obesity	9.11e-07	9.27e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—obesity	9.08e-07	9.24e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ESR1—obesity	9.07e-07	9.23e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ESR1—obesity	9.07e-07	9.23e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3R1—obesity	9.04e-07	9.2e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—obesity	9.04e-07	9.2e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PIK3CA—obesity	9.02e-07	9.18e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CD—obesity	9.01e-07	9.17e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CD—obesity	9.01e-07	9.17e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—obesity	9.01e-07	9.17e-06	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—obesity	8.98e-07	9.14e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—F2—obesity	8.96e-07	9.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—F2—obesity	8.96e-07	9.11e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCB—obesity	8.96e-07	9.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCB—obesity	8.96e-07	9.11e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—obesity	8.9e-07	9.05e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—obesity	8.9e-07	9.05e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—obesity	8.9e-07	9.05e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—obesity	8.9e-07	9.05e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK8—obesity	8.88e-07	9.03e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CG—obesity	8.86e-07	9.02e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—BAD—obesity	8.85e-07	9.01e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—BAD—obesity	8.85e-07	9.01e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARA—obesity	8.84e-07	8.99e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAV1—obesity	8.82e-07	8.97e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3R1—obesity	8.8e-07	8.95e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—obesity	8.8e-07	8.95e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—obesity	8.8e-07	8.95e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2E1—obesity	8.79e-07	8.95e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—obesity	8.78e-07	8.93e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IRS1—obesity	8.76e-07	8.91e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—INS—obesity	8.73e-07	8.88e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NQO1—obesity	8.69e-07	8.85e-06	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—obesity	8.69e-07	8.84e-06	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—obesity	8.69e-07	8.84e-06	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—obesity	8.62e-07	8.77e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK8—obesity	8.59e-07	8.74e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK8—obesity	8.59e-07	8.74e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CG—obesity	8.57e-07	8.72e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CG—obesity	8.57e-07	8.72e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—obesity	8.56e-07	8.71e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3R1—obesity	8.51e-07	8.66e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3R1—obesity	8.51e-07	8.66e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—obesity	8.51e-07	8.66e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—obesity	8.51e-07	8.66e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STAT3—obesity	8.48e-07	8.62e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IRS1—obesity	8.47e-07	8.62e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IRS1—obesity	8.47e-07	8.62e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—obesity	8.43e-07	8.58e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INS—obesity	8.39e-07	8.53e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—obesity	8.39e-07	8.53e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CB—obesity	8.34e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—obesity	8.34e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—obesity	8.34e-07	8.49e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GCG—obesity	8.34e-07	8.48e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC2A4—obesity	8.34e-07	8.48e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAV1—obesity	8.31e-07	8.45e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—obesity	8.29e-07	8.43e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—obesity	8.27e-07	8.41e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—obesity	8.25e-07	8.4e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYCS—obesity	8.23e-07	8.37e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—obesity	8.16e-07	8.3e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—obesity	8.16e-07	8.3e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CB—obesity	8.12e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—STAT3—obesity	8.12e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INS—obesity	8.11e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INS—obesity	8.11e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—obesity	8.11e-07	8.26e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT2—obesity	8.11e-07	8.25e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CD—obesity	8.1e-07	8.25e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GGT1—obesity	8.07e-07	8.21e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GOT1—obesity	8.07e-07	8.21e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—obesity	8.05e-07	8.19e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CG—obesity	8.03e-07	8.17e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—obesity	8e-07	8.14e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—obesity	7.99e-07	8.13e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—obesity	7.98e-07	8.12e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—obesity	7.98e-07	8.12e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NCOA1—obesity	7.95e-07	8.09e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PIK3CA—obesity	7.91e-07	8.05e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MYC—obesity	7.88e-07	8.01e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—obesity	7.86e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CB—obesity	7.86e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CB—obesity	7.86e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—obesity	7.85e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—STAT3—obesity	7.85e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—obesity	7.85e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—obesity	7.85e-07	7.99e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT2—obesity	7.84e-07	7.98e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT2—obesity	7.84e-07	7.98e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—STK11—obesity	7.84e-07	7.97e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP19A1—obesity	7.84e-07	7.97e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CD—obesity	7.79e-07	7.93e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—obesity	7.78e-07	7.92e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—obesity	7.78e-07	7.92e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—obesity	7.75e-07	7.89e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—obesity	7.7e-07	7.84e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3R1—obesity	7.65e-07	7.79e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—obesity	7.65e-07	7.79e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—obesity	7.64e-07	7.78e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—INS—obesity	7.6e-07	7.74e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CG—obesity	7.57e-07	7.7e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CD—obesity	7.54e-07	7.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CD—obesity	7.54e-07	7.67e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TYK2—obesity	7.49e-07	7.62e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—obesity	7.49e-07	7.62e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—obesity	7.45e-07	7.58e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—obesity	7.45e-07	7.58e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RHOA—obesity	7.43e-07	7.56e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—obesity	7.37e-07	7.5e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3R1—obesity	7.36e-07	7.48e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—obesity	7.36e-07	7.48e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—obesity	7.3e-07	7.43e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—obesity	7.29e-07	7.41e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TYK2—obesity	7.25e-07	7.38e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TYK2—obesity	7.25e-07	7.38e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—obesity	7.25e-07	7.38e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—obesity	7.25e-07	7.38e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—obesity	7.2e-07	7.33e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RHOA—obesity	7.19e-07	7.32e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RHOA—obesity	7.19e-07	7.32e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNB3—obesity	7.18e-07	7.31e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARGC1A—obesity	7.18e-07	7.31e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—INS—obesity	7.16e-07	7.29e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—obesity	7.15e-07	7.28e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3R1—obesity	7.12e-07	7.24e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3R1—obesity	7.12e-07	7.24e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—obesity	7.12e-07	7.24e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—obesity	7.12e-07	7.24e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CB—obesity	7.06e-07	7.19e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CD—obesity	7.06e-07	7.18e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PIK3CA—obesity	7.01e-07	7.13e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—obesity	7.01e-07	7.13e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—obesity	7e-07	7.12e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNAS—obesity	7e-07	7.12e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—obesity	6.97e-07	7.09e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—MYC—obesity	6.96e-07	7.08e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—obesity	6.95e-07	7.07e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOB—obesity	6.85e-07	6.97e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CB—obesity	6.79e-07	6.91e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MTOR—obesity	6.79e-07	6.91e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PIK3CA—obesity	6.78e-07	6.9e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PIK3CA—obesity	6.78e-07	6.9e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—MYC—obesity	6.74e-07	6.85e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—MYC—obesity	6.74e-07	6.85e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—obesity	6.72e-07	6.84e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—obesity	6.72e-07	6.84e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PIK3CA—obesity	6.69e-07	6.8e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—obesity	6.67e-07	6.78e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3R1—obesity	6.67e-07	6.78e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CD—obesity	6.65e-07	6.77e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CB—obesity	6.57e-07	6.68e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MTOR—obesity	6.57e-07	6.68e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MTOR—obesity	6.57e-07	6.68e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CB—obesity	6.57e-07	6.68e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—obesity	6.57e-07	6.68e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPL—obesity	6.54e-07	6.66e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—obesity	6.46e-07	6.58e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—PIK3CA—obesity	6.4e-07	6.51e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—obesity	6.38e-07	6.49e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—obesity	6.28e-07	6.39e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3R1—obesity	6.28e-07	6.39e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CD36—obesity	6.21e-07	6.32e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—obesity	6.2e-07	6.31e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—PIK3CA—obesity	6.19e-07	6.3e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—PIK3CA—obesity	6.19e-07	6.3e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CB—obesity	6.15e-07	6.26e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—obesity	6.1e-07	6.2e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—obesity	6e-07	6.11e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—obesity	6e-07	6.11e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—obesity	5.92e-07	6.02e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—PIK3CA—obesity	5.91e-07	6.01e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—obesity	5.9e-07	6e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—obesity	5.89e-07	5.99e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CB—obesity	5.8e-07	5.9e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARA—obesity	5.78e-07	5.88e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—obesity	5.75e-07	5.85e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—obesity	5.74e-07	5.84e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—obesity	5.72e-07	5.82e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—PIK3CA—obesity	5.72e-07	5.82e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—PIK3CA—obesity	5.72e-07	5.82e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—obesity	5.71e-07	5.81e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—obesity	5.71e-07	5.81e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—obesity	5.67e-07	5.77e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—obesity	5.6e-07	5.69e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—obesity	5.55e-07	5.65e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—obesity	5.55e-07	5.65e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—obesity	5.54e-07	5.63e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—obesity	5.54e-07	5.63e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—obesity	5.48e-07	5.58e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—obesity	5.48e-07	5.58e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—obesity	5.48e-07	5.58e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—obesity	5.46e-07	5.56e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAV1—obesity	5.43e-07	5.53e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—obesity	5.42e-07	5.51e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—obesity	5.25e-07	5.34e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—obesity	5.23e-07	5.33e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—obesity	5.23e-07	5.32e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CA—obesity	5.09e-07	5.18e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—obesity	5.08e-07	5.16e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—obesity	5.08e-07	5.16e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—obesity	5.06e-07	5.15e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—obesity	5.06e-07	5.15e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—obesity	5.06e-07	5.15e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—obesity	5.06e-07	5.15e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CA—obesity	4.95e-07	5.04e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CG—obesity	4.95e-07	5.03e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MYC—obesity	4.88e-07	4.96e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—obesity	4.86e-07	4.95e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—obesity	4.83e-07	4.91e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CA—obesity	4.79e-07	4.87e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CA—obesity	4.79e-07	4.87e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—obesity	4.78e-07	4.86e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MYC—obesity	4.72e-07	4.8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MYC—obesity	4.72e-07	4.8e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—obesity	4.71e-07	4.79e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—obesity	4.71e-07	4.79e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—obesity	4.71e-07	4.79e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INS—obesity	4.68e-07	4.77e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—obesity	4.67e-07	4.75e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—obesity	4.67e-07	4.75e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CD—obesity	4.35e-07	4.43e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CA—obesity	4.31e-07	4.38e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—obesity	4.29e-07	4.37e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—obesity	4.16e-07	4.23e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CA—obesity	4.14e-07	4.21e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3R1—obesity	4.11e-07	4.18e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—obesity	4.11e-07	4.18e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—obesity	4.04e-07	4.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CA—obesity	4e-07	4.07e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CA—obesity	4e-07	4.07e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—obesity	3.91e-07	3.98e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—obesity	3.91e-07	3.98e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CB—obesity	3.79e-07	3.86e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—obesity	3.76e-07	3.82e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CA—obesity	3.75e-07	3.82e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—obesity	3.67e-07	3.73e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—obesity	3.55e-07	3.61e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—obesity	3.55e-07	3.61e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CA—obesity	3.54e-07	3.6e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—obesity	3.52e-07	3.58e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—obesity	3.38e-07	3.44e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—obesity	3.27e-07	3.33e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—obesity	3.27e-07	3.33e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—obesity	3.06e-07	3.12e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—obesity	2.89e-07	2.94e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CA—obesity	2.31e-07	2.35e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—obesity	1.89e-07	1.92e-06	CbGpPWpGaD
